• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Transmembrane 7 superfamily member 3 (TM7SF3), Truncated

ACP08495

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08495 Target NameTM7SF3
Target SynonymsTM7SF3; Transmembrane 7 superfamily member 3; Seven span transmembrane proteinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9NS93
Background Information
  • Uniprot Id

    Q9NS93

  • Target Species

    Human

  • Target Name

    TM7SF3

  • Target Full Name

    Transmembrane 7 superfamily member 3

  • Target Function

    Involved in the inhibition of cytokine-induced death of pancreatic beta cells. Involved in the promotion of insulin secretion from pancreatic beta cells. Is a downstream transcriptional target of p53/TP53, and acts as a pro-survival homeostatic factor that attenuates the development of cellular stress. Maintains protein homeostasis and promotes cell survival through attenuation of endoplasmic reticulum (ER) stress and the subsequent induction of unfolded protein response (UPR).

  • Target Subcellular Location

    Cell membrane; Multi-pass membrane protein.

  • Target Tissue Specificity

    Widely expressed. Highly expressed in kidney and pancreas.

  • Target Synonyms

    TM7SF3; Transmembrane 7 superfamily member 3; Seven span transmembrane protein

Inquire Recombinant Human Transmembrane 7 superfamily member 3 (TM7SF3), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification